Morphine metabolism, transport and brain disposition

Area of Science:

• Pharmacology
• Neuroscience
• Drug Metabolism

Background:

• Morphine's analgesic effects and side effects are linked to its chemical structure and Blood Brain Barrier (BBB) penetration.
• Morphine metabolites, Morphine-6-glucuronide (M6G) and Morphine-3-glucuronide (M3G), exhibit different BBB permeability despite both being hydrophilic.
• M6G's ability to cross the BBB makes it a potentially more effective analgesic than morphine or M3G.

Purpose of the Study:

• To review recent advancements in understanding the brain disposition of M6G.
• To discuss the role of UDP-glucuronosyltransferases (UGTs) in morphine metabolism and their interindividual variability.
• To explore the involvement of transport proteins in the differential brain penetration of morphine metabolites.

Main Methods:

• Literature review of recent studies on M6G brain disposition.
• Analysis of research on UDP-glucuronosyltransferases (UGTs) involved in morphine metabolism.
• Examination of studies on transport proteins influencing metabolite passage across the BBB.

Main Results:

• M6G demonstrates significant penetration into the brain, contributing to its analgesic properties.
• UGTs play a crucial role in the glucuronidation of morphine, with significant interindividual variations observed.
• Specific transport proteins are implicated in the selective transport of M6G across the BBB.

Conclusions:

• M6G's enhanced BBB penetration is a key factor in its potent analgesic activity.
• Understanding UGT variability and transport protein function is vital for optimizing opioid therapy.
• Further research into these mechanisms can lead to the development of safer and more effective analgesics.